Clinical Trial Update: Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of capecitabine and Pseudomonas aeruginosa for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pseudomonas aeruginosa (Pseudomonas aeruginosa)
• Xeloda (capecitabine)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED